<DOC>
	<DOC>NCT00002052</DOC>
	<brief_summary>To compare the effectiveness of standard treatment with parenteral ampicillin and oral amoxicillin compared to initial daily therapy with ceftriaxone followed by 3 times weekly suppressive treatment for salmonella infections in AIDS patients.</brief_summary>
	<brief_title>Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Salmonella Infections</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Ampicillin</mesh_term>
	<criteria>Exclusion Criteria Coexisting Condition: Patients with the following are excluded: Type I hypersensitivity to betalactam antibiotics. Not expected to survive 12 weeks. In a coma or with other central nervous system (CNS) impairment. Patients with the following are excluded: Type I hypersensitivity to betalactam antibiotics. Not expected to survive 12 weeks. In a coma or with other central nervous system (CNS) impairment. Prior Medication: Excluded within 48 hours of study entry: Treatment with an antibiotic active in vitro against Salmonella. HIV infection, AIDS, or AIDS related complex (ARC). Salmonella bacteremia or positive stool culture in patient with 3 or more stools per day.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 1989</verification_date>
	<keyword>Salmonella Infections</keyword>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Amoxicillin</keyword>
	<keyword>Ceftriaxone</keyword>
</DOC>